Full video transcriptClick to expand
Auto-generated transcript of @katridzcvfx's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:01I
SHBG and TRT: Does bound testosterone really not count?
Quick answer
SHBG is a legitimate variable in testosterone assessment, particularly when total testosterone is borderline or when metabolic conditions like obesity or liver disease are present. The Endocrine Society recommends free or bioavailable testosterone measurement in specific clinical scenarios, not as a routine add-on to every TRT panel. TRT non-response has multiple causes, and attributing it primarily to SHBG without ruling out comorbidities is clinically incomplete.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 8 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For SHBG and TRT: Does bound testosterone really not count?, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
NAD+ metabolism and its roles in cellular processes during ageing
Core review for NAD+ decline, mitochondrial function, DNA repair, and aging biology.
PubMed
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Human NMN source for metabolic claims while keeping population limits clear.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
SHBG and TRT: Does bound testosterone really not count? is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "SHBG and TRT: Does bound testosterone really not count?" from Alles im Wechsel. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: SHBG is a legitimate variable in testosterone assessment, particularly when total testosterone is borderline or when metabolic conditions like obesity or liver disease are present.
The reason this review is not generic is the source wording and the canonical claim label "trt du nimmst testosteron aber sp rst kaum einen unterschied dan." In this clip, the useful excerpt is: "I" That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
SHBG is a legitimate variable in testosterone assessment, particularly when total testosterone is borderline or when metabolic conditions like obesity or liver disease are present.
FormBlends verdict
Testosterone evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- SHBG is a legitimate variable in testosterone assessment, particularly when total testosterone is borderline or when metabolic conditions like obesity or liver disease are present. The Endocrine Society recommends free or bioavailable testosterone measurement in specific clinical scenarios, not as a routine add-on to every TRT panel. TRT non-response has multiple causes, and attributing it primarily to SHBG without ruling out comorbidities is clinically incomplete.
- SHBG binds testosterone with high affinity, reducing the fraction available to tissues, but the bound-equals-inactive model is an oversimplification supported by older biochemistry rather than current mechanistic research.
- Free testosterone measured by equilibrium dialysis is the gold standard, but calculated free testosterone using the Vermeulen equation is an acceptable clinical proxy per Rosner et al. (2007, JCEM).
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- SHBG binds testosterone with high affinity, reducing the fraction available to tissues, but the bound-equals-inactive model is an oversimplification supported by older biochemistry rather than current mechanistic research.
- Free testosterone measured by equilibrium dialysis is the gold standard, but calculated free testosterone using the Vermeulen equation is an acceptable clinical proxy per Rosner et al. (2007, JCEM).
- The Endocrine Society 2018 guidelines recommend free or bioavailable testosterone testing when total testosterone is borderline or SHBG abnormality is clinically suspected, not routinely for all TRT patients.
- TRT non-response has multiple documented causes including sleep apnea, insulin resistance, thyroid dysfunction, and depression. Attributing it to SHBG alone without a full workup is clinically incomplete.
- Supplements marketed as SHBG reducers, including boron and nettle root, lack randomized controlled trial evidence in hypogonadal men and should not be used as a substitute for clinical evaluation.
- Men with obesity typically have lower SHBG and suppressed total testosterone but relatively preserved free testosterone, while older men and those with liver disease often show the opposite pattern.
- Requesting an SHBG panel based on TikTok content is not inherently harmful, but using it to self-justify dose escalation or add-on compounds without physician oversight carries real risk.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What's this video probably claiming?
Based on the caption, the creator is arguing that sex hormone-binding globulin (SHBG) renders a significant portion of circulating testosterone biologically inactive, and that men on testosterone replacement therapy (TRT) who still feel symptomatic may be experiencing the effects of high SHBG rather than genuinely low testosterone. The implied takeaway is that total testosterone numbers can look fine on paper while free testosterone, the fraction not bound to SHBG or albumin, remains too low to produce clinical benefit. This is a real physiological concept, not fabricated wellness content. But the way it tends to get framed on TikTok, and likely here, skips over enough nuance to push men toward conclusions the evidence does not fully support. The creator appears to be targeting men already on TRT who feel underwhelmed by results, which is a legitimate clinical population worth discussing seriously.
What does the science actually show?
The basic biochemistry is accurate. SHBG binds testosterone with high affinity, and only free testosterone plus weakly albumin-bound testosterone are considered bioavailable. Rosner et al. (2007, Journal of Clinical Endocrinology and Metabolism) showed that free testosterone calculated via the Vermeulen equation correlates reasonably well with measured free testosterone by equilibrium dialysis, the gold standard. However, the clinical significance of SHBG-bound testosterone is not as simple as bound equals useless. Anderson (1974, Journal of Endocrinology) and more recent work by Handelsman (2017, Andrology) both argue that SHBG-testosterone complexes may dissociate at tissue level faster than early models assumed. Separately, a 2020 study by Travison et al. in JCEM found that free testosterone thresholds for symptom onset vary considerably between individuals, meaning population-level reference ranges are a poor guide for any one patient. The signal here is real. The certainty with which it gets delivered on social media is not.
Where does the social media noise diverge from clinical reality?
The creator's framing, your total T looks normal but you are not getting enough, is a popular narrative that has outrun its evidence base. It is used to justify higher testosterone doses, add-on compounds like anastrozole to suppress SHBG indirectly, or supplements like boron and nettle root that circulate in TRT communities as SHBG reducers. None of those interventions have strong randomized controlled trial data supporting their use in eugonadal or treated hypogonadal men. Camacho et al. (2013, European Journal of Endocrinology) noted that calculated free testosterone adds diagnostic value in men with borderline total testosterone, not in men already on replacement therapy where the dynamic is different. The bigger clinical reality is that TRT non-response has multiple causes including sleep apnea, insulin resistance, thyroid dysfunction, and depression, none of which SHBG explains. Focusing on SHBG as the single variable risks misattributing symptoms and delaying proper workup.
What should you actually know?
SHBG testing does have a legitimate place in TRT management. Men with obesity tend to have lower SHBG and may have suppressed total testosterone with relatively preserved free testosterone. Older men and those with liver disease or thyroid disorders often have elevated SHBG that genuinely distorts total T readings. The Endocrine Society's 2018 clinical practice guidelines on male hypogonadism recommend measuring free or bioavailable testosterone when total testosterone is near the lower limit of normal or when SHBG abnormality is suspected, not routinely for everyone on TRT. If a video like this sends men to their doctor asking for SHBG panels, that is probably harmless or even useful. If it sends them to a supplement stack or to lobby their prescriber for a higher dose based on a TikTok explanation of binding affinity, that is where the harm sits. The concept is real. The certainty of its application in any individual is not.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Alles im Wechsel · TikTok creator
15.0K views on this video
Du nimmst Testosteron, aber spürst kaum einen Unterschied? Dann lohnt sich ein Blick auf dein SHBG Sexualhormon-bindendes Globulin bindet Testosteron im Blut. 👉 Gebunden = nicht aktiv 👉 Nur freies Testosteron wirkt Das bedeutet: Dein Wert kann „normal“ sein, aber dein Körper bekommt zu wenig davon ab. 👉 Der FAI zeigt, wie viel wirklich verfügbar ist (Testosteron im Verhältnis zu SHBG). 🔬 SHBG: ca. 30–70 FAI: ca. 0,5–5 👉 Zu hohes SHBG = zu wenig wirksames Testosteron Gerade in der Perimenopa
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about shbg binds testosterone with high affinity, reducing the fraction available?
SHBG binds testosterone with high affinity, reducing the fraction available to tissues, but the bound-equals-inactive model is an oversimplification supported by older biochemistry rather than current mechanistic research.
What does the video say about free testosterone measured by equilibrium dialysis?
Free testosterone measured by equilibrium dialysis is the gold standard, but calculated free testosterone using the Vermeulen equation is an acceptable clinical proxy per Rosner et al. (2007, JCEM).
What does the video say about the endocrine society 2018 guidelines recommend free?
The Endocrine Society 2018 guidelines recommend free or bioavailable testosterone testing when total testosterone is borderline or SHBG abnormality is clinically suspected, not routinely for all TRT patients.
What does the video say about trt non-response has multiple documented causes including sleep apnea, insulin?
TRT non-response has multiple documented causes including sleep apnea, insulin resistance, thyroid dysfunction, and depression. Attributing it to SHBG alone without a full workup is clinically incomplete.
What does the video say about supplements marketed as shbg reducers, including boron?
Supplements marketed as SHBG reducers, including boron and nettle root, lack randomized controlled trial evidence in hypogonadal men and should not be used as a substitute for clinical evaluation.
What does the video say about men with obesity typically have lower shbg?
Men with obesity typically have lower SHBG and suppressed total testosterone but relatively preserved free testosterone, while older men and those with liver disease often show the opposite pattern.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Not medical advice. This video was made by Alles im Wechsel, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.